Sign in
NXTS Stock Price, Chart, Stats & News
Nexentis Technologies Inc.
Save
Nexentis Technologies Inc. (NXTS) does not currently pay a dividend.
148,845
Market cap
–
Current P/E
–
Forward P/E
NXTS chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.56% |
Operating margin | -2641.93% |
Pretax margin | -3284.97% |
Net margin | -3208.23% |
Effective tax rate | – |
ROA | -60.67% |
ROE | -114.43% |
D/E | 0.13x |
Interest coverage ratio | -2.68x |
NXTS valuation
P/E | – |
P/S | 8.46x |
P/B | 0.07x |
P/CF | -0.21x |
P/FCF | -0.60x |
P/OCF | -0.21x |
PEG | -0.00x |
EV multiple | -1.22x |
About
Nexentis Technologies Inc., through its subsidiary, develops therapeutics related to cancer and inflammatory metabolic diseases. It operates through two segments, Biotechnology Activity and Renewable Energy Projects. The company's pipeline includes MITOLINE, an algorithm used to perform multiple sequence/ structure pairwise alignments which could then be used for generating a 3D comparative model of potentially all mitochondrial carrier proteins; cloud-based computational chemistry platform; and novel in-vitro screening platforms; and advanced 3D NSCLC tumor spheroid systems.
Similar securities
Based on sector and market capitalization
Report issue